Literature DB >> 2381495

Neuritic plaques and vessels of visual cortex in aging and Alzheimer's dementia.

M A Bell1, M J Ball.   

Abstract

Changes in microvascular dimensions occurring with normal aging and Alzheimer's dementia were measured in thick sections of postmortem human visual cortex stained for alkaline phosphatase. Capillary density was decreased to the same degree in both normal aged and demented aged subjects. The fields selected for analysis in both groups included all cortical laminae and, where possible, amyloid-cored neuritic plaques. The mean density of such plaques in these selected fields was slightly but not significantly higher in the demented group. In both groups plaques were more plentiful in visual laminae with the highest capillary densities (II-IV), but plaques and vessels were closer to each other in the normal aged than in the demented. Plaque distributions differed; in the normal aged, plaques concentrated in lamina IV; in the demented they were more evenly spread throughout the laminae. Plaque cores were larger in the demented. Amyloid angiopathy was more common and more extensive in the demented group; amyloid-cored plaques were not closely associated with affected vessels. Plaque distributions in Alzheimer subjects with and without amyloid angiopathy differed; plaque density was greatest in those without angiopathy. Alzheimer's dementia was not associated with any decline in microvascularity. Plaque concentration in well vascularized laminae suggests a pathogenetic role for some blood-borne agent. Differences in plaque distributions imply that the role or the agent differs in normal and demented aging, or perhaps between cases with and without amyloid angiopathy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2381495     DOI: 10.1016/0197-4580(90)90001-g

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  18 in total

1.  Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex.

Authors:  T G Beach; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Clustering of tau-immunoreactive pathology in chronic traumatic encephalopathy.

Authors:  Richard A Armstrong; Ann C McKee; Victor E Alvarez; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2016-10-21       Impact factor: 3.575

3.  Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein.

Authors:  Jianting Miao; Feng Xu; Judianne Davis; Irene Otte-Höller; Marcel M Verbeek; William E Van Nostrand
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders.

Authors:  L Buée; P R Hof; C Bouras; A Delacourte; D P Perl; J H Morrison; H M Fillit
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.

Authors:  C S Janota; D Brites; C A Lemere; M A Brito
Journal:  Brain Res       Date:  2015-05-09       Impact factor: 3.252

Review 6.  Review: cerebral microvascular pathology in ageing and neurodegeneration.

Authors:  W R Brown; C R Thore
Journal:  Neuropathol Appl Neurobiol       Date:  2011-02       Impact factor: 8.090

7.  Analysis of beta-amyloid (Abeta) deposition in the temporal lobe in Alzheimer's disease using Fourier (spectral) analysis.

Authors:  R A Armstrong; N J Cairns
Journal:  Neuropathol Appl Neurobiol       Date:  2010-01-29       Impact factor: 8.090

8.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.

Authors:  Stefano Tarantini; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Peter Toth; Tripti Gautam; Cory B Giles; Praveen Ballabh; Jeanne Y Wei; Jonathan D Wren; Nicole M Ashpole; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-09-09

9.  Expression of leukocyte antigen CD34 by brain capillaries in Alzheimer's disease and neurologically normal subjects.

Authors:  R N Kalaria; S N Kroon
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.

Authors:  Sandra L Siedlak; Gemma Casadesus; Kate M Webber; Miguel A Pappolla; Craig S Atwood; Mark A Smith; George Perry
Journal:  Free Radic Res       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.